S Bhandari S,
Charles CJ, Miller AP, Scott-Thomas A, Chambers ST.,
Pathology, dose response and tolerance to cyclophosphamide and as a model for
immuno-suppression in sheep, Online J Vet Res., 16 (3):96-103, 2012. Cyclophosphamide is
one of the most common chemotherapy drugs used to produce immunosuppressed
animal models of disease. This study was aimed at developing an
immunosuppressed sheep model of invasive aspergillosis using cyclophosphamide.
Six female Coopworth sheep were dosed with
cyclophosphamide at 30, 45, 60 or 75mg/kg body weight with the intention of
inducing neutropenia. There was a dose-dependent reduction in
neutrophil count but this was mild and transient at doses of 30 and 45
mg/kg. All animals dosed with 60 mg/kg
had a nadir of less than 0.5 x109/L but this was relatively
short-lived. All animals showed
respiratory distress and loss of appetite commencing as early as 24h following
cyclophosphamide dosing with rapid deterioration of general health requiring
euthanasia. At post-mortem
examination, the lungs of all the sheep showed features of diffuse alveolar
damage (DAD) characterized by diffuse edema, focal alveolar hemorrhage,
consolidation and congestion. Bacterial
and fungal culture of the lung homogenate was always negative. On the basis of
these findings, it was concluded that these animals suffered from
cyclophosphamide-induced DAD with acute respiratory distress syndrome and it
was not possible to establish a sheep model of invasive aspergillosis.
FULL-TEXT (SUBSCRIPTION OR PURCHASE TITLE $25USD)